David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
Oscar Health
OSCR
$9.64B
| $3.87M | ﹤0.01% |
295,491
+172,341
| +140% | +$2.56M |
|
|
AVDL
1977
DELISTED
Avadel Pharmaceuticals
AVDL
| $3.87M | ﹤0.01% |
494,678
+185,020
| +60% | +$1.55M |
|
1978
PUT
TFI International
TFII
$11.1B
| $3.87M | ﹤0.01% |
50,000
+25,000
| +100% | +$2.77M |
|
1979
Mueller Industries
MLI
$14.2B
| $3.87M | ﹤0.01% |
101,680
+60,532
| +147% | +$2.42M |
|
1980
Employers Holdings
EIG
$883M
| $3.87M | ﹤0.01% |
76,437
+36,935
| +94% | +$1.83M |
|
|
HAPN
1981
Happen Inc
HAPN
$2.12B
| $3.85M | ﹤0.01% |
373,509
-65,459
| -15% | -$878K |
|
1982
Weis Markets
WMK
$1.75B
| $3.85M | ﹤0.01% |
50,021
-11,400
| -19% | -$820K |
|
1983
Dorman Products
DORM
$3.84B
| $3.85M | ﹤0.01% |
31,972
-7,780
| -20% | -$992K |
|
1984
Acushnet Holdings
GOLF
$5.07B
| $3.85M | ﹤0.01% |
56,128
-112,694
| -67% | -$7.65M |
|
1985
PUT
Eastman Chemical
EMN
$8.34B
| $3.85M | ﹤0.01% |
+43,700
| New | +$4.13M |
|
1986
CALL
Interactive Brokers
IBKR
$44B
| $3.84M | ﹤0.01% |
92,800
+7,600
| +9% | +$377K |
|
1987
Newmark Group
NMRK
$2.86B
| $3.84M | ﹤0.01% |
315,584
+265,104
| +525% | +$3.54M |
|
1988
CALL
Trade Desk
TTD
$6.12B
| $3.84M | ﹤0.01% |
70,100
-47,400
| -40% | -$4.29M |
|
1989
Organogenesis Holdings
ORGO
$225M
| $3.82M | ﹤0.01% |
884,288
+146,845
| +20% | +$593K |
|
1990
Upland Software
UPLD
$13.3M
| $3.82M | ﹤0.01% |
133,563
+3,457
| +3% | +$131K |
|
1991
Scansource
SCSC
$1.14B
| $3.81M | ﹤0.01% |
+112,096
| New | +$4.57M |
|
1992
CALL
Edison International
EIX
$28.7B
| $3.81M | ﹤0.01% |
64,700
-54,200
| -46% | -$3.12M |
|
1993
Dave & Buster's
PLAY
$343M
| $3.8M | ﹤0.01% |
216,558
+73,048
| +51% | +$1.73M |
|
1994
CALL
ON Semiconductor
ON
$28.5B
| $3.8M | ﹤0.01% |
93,300
+26,000
| +39% | +$1.31M |
|
1995
PUT
Marriott International
MAR
$93.5B
| $3.79M | ﹤0.01% |
+15,900
| New | +$4.32M |
|
1996
Castle Biosciences
CSTL
$1.04B
| $3.79M | ﹤0.01% |
189,177
+98,614
| +109% | +$2.44M |
|
1997
CALL
Pinterest
PINS
$13.2B
| $3.78M | ﹤0.01% |
122,000
-13,400
| -10% | -$454K |
|
1998
Huron Consulting
HURN
$2.49B
| $3.78M | ﹤0.01% |
26,360
+3,544
| +16% | +$477K |
|
1999
Telus
TU
$15.3B
| $3.78M | ﹤0.01% |
263,382
+133,936
| +103% | +$1.96M |
|
|
NXDR
2000
Nextdoor Holdings
NXDR
$886M
| $3.75M | ﹤0.01% |
2,452,625
+370,143
| +18% | +$827K |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.